These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38416036)

  • 1. Plitidepsin as an Immunomodulator against Respiratory Viral Infections.
    Losada A; Izquierdo-Useros N; Aviles P; Vergara-Alert J; Latino I; Segalés J; Gonzalez SF; Cuevas C; Raïch-Regué D; Muñoz-Alonso MJ; Perez-Zsolt D; Muñoz-Basagoiti J; Rodon J; Chang LA; Warang P; Singh G; Brustolin M; Cantero G; Roca N; Pérez M; Bustos-Morán E; White K; Schotsaert M; García-Sastre A
    J Immunol; 2024 Apr; 212(8):1307-1318. PubMed ID: 38416036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
    Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z
    Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral effect of fufang yinhua jiedu (FFYH) granules against influenza A virus through regulating the inflammatory responses by TLR7/MyD88 signaling pathway.
    Zhang Y; Wang R; Shi W; Zheng Z; Wang X; Li C; Zhang S; Zhang P
    J Ethnopharmacol; 2021 Jul; 275():114063. PubMed ID: 33813013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A.
    White KM; Rosales R; Yildiz S; Kehrer T; Miorin L; Moreno E; Jangra S; Uccellini MB; Rathnasinghe R; Coughlan L; Martinez-Romero C; Batra J; Rojc A; Bouhaddou M; Fabius JM; Obernier K; Dejosez M; Guillén MJ; Losada A; Avilés P; Schotsaert M; Zwaka T; Vignuzzi M; Shokat KM; Krogan NJ; García-Sastre A
    Science; 2021 Feb; 371(6532):926-931. PubMed ID: 33495306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the antiviral activity of plitidepsin against SARS-CoV-2 by subcellular and morphological analysis.
    Sachse M; Tenorio R; Fernández de Castro I; Muñoz-Basagoiti J; Perez-Zsolt D; Raïch-Regué D; Rodon J; Losada A; Avilés P; Cuevas C; Paredes R; Segalés J; Clotet B; Vergara-Alert J; Izquierdo-Useros N; Risco C
    Antiviral Res; 2022 Apr; 200():105270. PubMed ID: 35231500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liu Shen Wan inhibits influenza a virus and excessive virus-induced inflammatory response via suppression of TLR4/NF-κB signaling pathway in vitro and in vivo.
    Ma Q; Huang W; Zhao J; Yang Z
    J Ethnopharmacol; 2020 Apr; 252():112584. PubMed ID: 31972325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavonoids from Houttuynia cordata attenuate H1N1-induced acute lung injury in mice via inhibition of influenza virus and Toll-like receptor signalling.
    Ling LJ; Lu Y; Zhang YY; Zhu HY; Tu P; Li H; Chen DF
    Phytomedicine; 2020 Feb; 67():153150. PubMed ID: 31958713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hunting the main protease of SARS-CoV-2 by plitidepsin: Molecular docking and temperature-dependent molecular dynamics simulations.
    Vishvakarma VK; Singh MB; Jain P; Kumari K; Singh P
    Amino Acids; 2022 Feb; 54(2):205-213. PubMed ID: 34807314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sinensetin suppresses influenza a virus-triggered inflammation through inhibition of NF-κB and MAPKs signalings.
    Li J; Jie X; Liang X; Chen Z; Xie P; Pan X; Zhou B; Li J
    BMC Complement Med Ther; 2020 May; 20(1):135. PubMed ID: 32370749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational Prediction of the Potential Target of SARS-CoV-2 Inhibitor Plitidepsin via Molecular Docking, Dynamic Simulations and MM-PBSA Calculations.
    El Hassab MA; Hemeda LR; Elsayed ZM; Al-Rashood ST; Abdel-Hamid Amin MK; Abdel-Aziz HA; Eldehna WM
    Chem Biodivers; 2022 Feb; 19(2):e202100719. PubMed ID: 34813168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action.
    Ma Q; Wang Z; Chen R; Lei B; Liu B; Jiang H; Chen Z; Cai X; Guo X; Zhou M; Huang J; Li X; Dai J; Yang Z
    Phytomedicine; 2022 Jan; 95():153874. PubMed ID: 34923232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cangma Huadu granules, a new drug with great potential to treat coronavirus and influenza infections, exert its efficacy through anti-inflammatory and immune regulation.
    Cui XR; Guo YH; Liu QQ
    J Ethnopharmacol; 2022 Apr; 287():114965. PubMed ID: 34990767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory and antiviral activities of cynanversicoside A and cynanversicoside C isolated from Cynanchun paniculatum in influenza A virus-infected mice pulmonary microvascular endothelial cells.
    Wei P; Zhang T; Dong H; Chen Q; Mu X; Hu G
    Phytomedicine; 2017 Dec; 36():18-25. PubMed ID: 29157813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Methoxyflavone-induced AMPKα activation inhibits NF-κB and P38 MAPK signaling to attenuate influenza A virus-mediated inflammation and lung injury in vitro and in vivo.
    Yang S; Wang L; Pan X; Liang Y; Zhang Y; Li J; Zhou B
    Cell Mol Biol Lett; 2022 Sep; 27(1):82. PubMed ID: 36180831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. San Wu Huangqin decoction regulates inflammation and immune dysfunction induced by influenza virus by regulating the NF-κB signaling pathway in H1N1-infected mice.
    Ma QH; Ren MY; Luo JB
    J Ethnopharmacol; 2021 Jan; 264():112800. PubMed ID: 32224195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2.
    Su CM; Wang L; Yoo D
    Sci Rep; 2021 Jun; 11(1):13464. PubMed ID: 34188167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes and clinical characteristics of the compassionate use of plitidepsin in COVID-19 patients with solid tumours, haematological malignancies or anti-CD20 antibody treatment.
    Aguareles J; Villares Fernández P; Forné C; Martí-Ballesteros EM; Pradillo Fernández V; Sotres-Fernandez G; de la Fuente-Burguera A; Navarro-San Francisco C; Buzón-Martín LM; García-Delangue T; Aiello FT; Carnevali-Ruiz D; Lloris R; Luepke-Estefan XE; López-Martín JA; Jimeno JM; García-Casas A; Guisado-Vasco P
    Infect Dis (Lond); 2024 Jul; 56(7):575-580. PubMed ID: 38743059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-H1N1 influenza effects and its possible mechanism of Huanglian Xiangru Decoction.
    Wu QF; Zhu WR; Yan YL; Zhang XX; Jiang YQ; Zhang FL
    J Ethnopharmacol; 2016 Jun; 185():282-8. PubMed ID: 26940899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aurantiamide acetate from baphicacanthus cusia root exhibits anti-inflammatory and anti-viral effects via inhibition of the NF-κB signaling pathway in Influenza A virus-infected cells.
    Zhou B; Yang Z; Feng Q; Liang X; Li J; Zanin M; Jiang Z; Zhong N
    J Ethnopharmacol; 2017 Mar; 199():60-67. PubMed ID: 28119097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel effect of methionine enkephalin against influenza A virus infection through inhibiting TLR7-MyD88-TRAF6-NF-κB p65 signaling pathway.
    Tian J; Jiao X; Wang X; Geng J; Wang R; Liu N; Gao X; Griffin N; Shan F
    Int Immunopharmacol; 2018 Feb; 55():38-48. PubMed ID: 29220721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.